Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, along with the Limited Review Report by Statutory Auditors. 2. Proposal for the reconstitution of various Committees of the Board of Directors.

30/09/2026 Department of Corporate Services, BSE Limited, P.J. Tower, Dalal Street, Mumbai – 400001. Scrip Code: 526445 Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that, Meeting of the Board of Directors will be held on Wednesday, 7th October, 2026, inter alia, to consider and approve the following: 1. Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, along with the Limited Review Report by Statutory Auditors. 2. Proposal for the reconstitution of various Committees of the Board of Directors. 3. Any other business with permission of the chair. You are requested to take the above on record and disseminate the information on your website. Thanking You, For Indrayani Biotech Limited Swaminathan Govindarajan Whole-time Director DIN:02481041 Block 1, 33, SIDCO Electronic Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600032 Ph: +91-44-24463751 / +91-44-22502146 | www.indrayani.com | info@indrayani.com | CIN: L40100TN1992PLC129301